Please support Telehealth.org’s ability to deliver helpful news, opinions, and analyses by turning off your ad blocker.
Patients with mild cognitive impairment (MCI) will be piloting a new remote monitoring (RPM) technology through Nuvance Health in West Connecticut, one of the first health systems in the United States to pilot RPM with this population. Neuroglee Connect™ is a virtual neurological specialty care program for clinical care teams to provide ongoing, personalized support for patients with MCI and caregivers from their homes. The program includes the use of remote patient monitoring services.
According to the Alzheimer’s Association, 12% to 18% of people aged 60 and older currently have MCI in the United States. MCI is an early stage of memory loss or other cognition problems. Issues involve difficulty with language and thinking. While MCI is not a type of dementia, the Alzheimer’s Association estimates 10% to 15% of people with MCI eventually develop dementia every year.
Remote Patient Monitoring Service for Mild Cognitive Impairment
Remote patient monitoring includes digital therapeutics with no approved medications to treat MCI. Current guidelines advocate regular brain stimulation paired with healthy lifestyle habits can be helpful to patients with MCI. Often involving brain stimulation systems that use digital and often Internet-based health technology, digital therapeutics have been shown to help patients with Alzheimer’s disease and other forms of dementia. Digital therapeutics (DTx) involves using evidence-based behavioral treatments delivered online to increase the accessibility and effectiveness of healthcare interventions. They differ from apps, which often lack the scientific testing and approval offered by groups such as the US Federal Drug Administration.
Neuroglee Connect™Remote Patient Monitoring Service
Through its Neuroscience Institute, Nuvance Health’s Neuroglee Connect™is a remote patient monitoring service that includes brain-stimulating activities that can measure performance through timely assessments and identify signs of deterioration in people of all ages, especially older adults.
In a recent press release, the company explained:
The remote monitoring program Nuvance Health has made available through its Neuroscience Institute includes brain-stimulating activities that can measure performance through timely assessments and identify signs of deterioration. A digital dashboard captures this information in real time for neurologists who can provide ongoing therapy modifications based on real-world data while efficiently tracking each patient’s adherence to the program.
A digital dashboard captures this information in real time for neurologists who can provide ongoing therapy modifications based on real-world data while efficiently tracking each patient’s adherence to the program. Neuroglee is also known for other digital therapeutic products attacking neurodegenerative diseases, including Alzheimer’s.
BCTP®-III Telehealth Training & Certificate
Join the elite professionals who have immersed themselves in the depths of telehealth training, obtained monthly group consultation to tailor their learning to their needs, and earned the coveted BCTP®-III distinction!
Disclaimer: Telehealth.org offers information as educational material designed to inform you of issues, products, or services potentially of interest. We cannot and do not accept liability for your decisions regarding any information offered. Please conduct your due diligence before taking action. Also, the views and opinions expressed are not intended to malign any organization, company, or individual. Product names, logos, brands, and other trademarks or images are the property of their respective trademark holders. There is no affiliation, sponsorship, or partnership suggested by using these brands unless contained in an ad. We do not and cannot offer legal, ethical, billing technical, medical, or therapeutic advice. Use of this site constitutes your agreement to Telehealth.org Privacy Policy and Terms and Conditions.
